Ortho Roundup: Strong Knees Let SYK Stands Tall Against Recon Rivals ZMH, SNN And JNJ
The top four orthopedic implant makers have released their second-quarter and half-year results. Following DePuy Synthes report of a still-soft but recovering reconstructive implant market, this edition of Earnings Winners And Losers look at how the other three big recon players – Zimmer Biomet, Stryker, and Smith & Nephew fare. It also offers a peek into the top- and bottom-line results of the other key names within Medtech Insight's Top 10 orthopedic companies.
You may also be interested in...
Zimmer Biomet saw increased growth during the second quarter – but the company also confirmed on its recent Q2 earnings call that its quality remediation efforts continue, with fresh FDA observations arising from the agency's most recent inspection of one of Zimmer's Indiana-based manufacturing facilities.
Earnings season kicked off last week with Johnson & Johnson, Abbott, Danaher and Intuitive Surgical being among the first wave of second-quarter and first-half results to be released. Abbott, J&J and Danaher experienced steady growth, but robotic surgery leader Intuitive announced some particularly nice numbers, beating analyst expectations.
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.